Yahoo
NasdaqGS - Nasdaq Real Time Price USD

Neumora Therapeutics, Inc. (NMRA)

0.5033 +0.0163 (+3.35%)
At close: November 6 at 4:00:00 PM EST
0.5200 +0.0167 (+3.32%)
After hours: November 6 at 6:12:45 PM EST
Trade NMRA on Coinbase
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements have been upgraded
A new layout with more detail in every statement.
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Cash Flow from Operating Activities, Indirect
-180,520 -206,440 -182,936 -163,278 -114,896
Cash Flow from Investing Activities
94,034 168,520 -70,557 64,387 -168,013
Cash Flow from Financing Activities
78,797 77,089 21,603 231,936 115,743
Cash and Cash Equivalents, End of Period
116,834 182,530 143,361 375,251 242,206
Cash Flow, Supplemental
Free Cash Flow to Firm
-178,253.9700 -203,459.9900 -205,572 -154,496 -108,459
Capital Expenditure, Calculated
0 -- 0 117 511
Issuance of Capital Stock
40,024 19,653 13,694 233,375 112,216
Repurchase of Capital Stock
0 0 0 -491 0
12/31/2022 - 9/14/2023

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: